Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Exercise/Conversion of 8,541 ORKA shares, $106.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 8,541 | $106.8K |
| Sep 21, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 533 | $51.0K |
| Sep 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 8,000 | $100.0K |
| Aug 14, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 8,542 | $106.8K |
| Jul 13, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 8,541 | $106.8K |
| Jun 22, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 888 | $71.0K |
| Jun 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 8,000 | $100.0K |
| May 18, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 2,000 | $25.0K |
| Mar 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 395 | $16.3K |
| Jan 23, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 17,500 | n/a |